Firestone Karen

Amylyx Pharmaceuticals, Inc. · Director

Firestone Karen is listed in filings as Director at Amylyx Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including purchase activity. Recent filings connect the profile to Amylyx Pharmaceuticals, Inc. (AMLX). The current snapshot covers public activity from Sep 9, 2024 to May 26, 2026. Reported amounts are shown as $51.3K to $126.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Amylyx Pharmaceuticals, Inc.AMLX$101k8.1k sharesBuyDec 23, 2025$12.45$17.02
Amylyx Pharmaceuticals, Inc.AMLX$107k50k sharesBuySep 5, 2024$2.13$17.02